Apyx Medical Corporation announced that the company has enhanced its clinical and regulatory affairs teams with the appointment of Kari Larson and Libet Garber, to the positions of Senior Director of Clinical Affairs and Director of Global Regulatory Affairs, respectively. Ms. Larson joins Apyx Medical with over 15 years of clinical research experience at both healthcare companies and clinical sites. Prior to joining Apyx Medical, Ms. Larson was the Director of Clinical Research for Lutronic Global from 2017 until 2019 where she was responsible for the execution and management of the company’s U.S. clinical trials. Lutronic Global is a division of Lutronic Corp., a global aesthetic laser company based in Korea and listed on the KOSDAQ. From 2011 until 2017, she was the Senior Director of Clinical Affairs for Ulthera Inc. Prior to joining Apyx Medical, Dr. Garber led reviews of over 700 regulatory submissions (including complex De Novos, Pre-Submissions, IDEs, PMAs and 510(k)s for multiple types of devices) as a Master Scientific Reviewer at the U.S. Food and Drug Administration’s Office of Device Evaluation from 2009 until 2019. In her tenure with the FDA, Dr. Garber gained extensive regulatory writing experience including authoring FDA guidance documents, and developing pre-clinical test methods and clinical study designs for novel devices that did not have existing performance standards.